Treatment offers
Leave space to pause over a treatment offer.
An offer can sound tidy and still leave the important parts unanswered. Keep the medicine name, the pharmacy and the person ordering the medicine in view. That person is called the prescriber.
The initials FDA stand for the US Food and Drug Administration.
| Wording or gap | What deserves a pause |
|---|---|
| No prescription needed | A seller cannot lawfully hand over prescription medicine without a prescription under the September 2026 federal rule. |
| Research use only | For research-labelled weight-loss drugs offered to people, FDA cautions about unknown quality and possible harm, as recorded in September 2026. |
| Compounded, meaning prepared to order, yet called approved | Compounded preparations do not carry FDA approval as of September 2026. |
| A badge in place of an answer | Official-looking seals and guarantees on a health website can be faked, according to the Federal Trade Commission. |
“Made for you” still calls for a reason
With compounding, the pharmacist or doctor prepares the patient’s medicine instead of supplying a finished manufacturer product.
Before sale, a compounded medicine has no FDA review of quality, safety or results, as recorded in September 2026.
A compounded medicine can meet a need an approved product cannot, according to FDA’s explanation recorded in September 2026.
Ask what need is being addressed in your case. The answer ought to go beyond a menu label.
Semaglutide is used for type 2 diabetes as Ozempic and for weight loss as Wegovy. Tirzepatide is used for type 2 diabetes as Mounjaro and for weight management as Zepbound.
When these medicines were officially in short supply, pharmacies could make copies of them. Both shortages had ended by September 2026.
For an approved medicine already being sold, an ordinary pharmacy could not make regular copies under the September 2026 rule.
Under the September 2026 rule, a changed medicine could be allowed if the prescriber decided the change made a significant difference for that specific patient.
A lower price alone does not make a medicine change qualify for that exception.
Ask what would change in the medicine and why that change matters for your care.
An unclear label needs a human answer
Errors in amounts of compounded semaglutide have been reported to FDA; some reports involved a hospital stay.
Get the pharmacist or prescriber to go over a label you cannot follow.
For concerns about care in Florida
Florida’s Department of Health takes written, signed complaints about licensed health workers and pharmacies; filing is free, though medical-record copies may cost money.
The department can take action on a licence, but it does not settle refund requests or arguments over bills.
Open the Florida complaint reading